FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095387515> ?p ?o ?g. }

• W2095387515 endingPage "51" @default.
• W2095387515 startingPage "46" @default.
• W2095387515 abstract "Intravenous levosimendan is indicated for acute heart failure. The compound has shown promising beneficial effects in ischemic stroke models.We evaluated the efficacy and safety of oral levosimendan in patients with a history of cerebral ischemia.In a randomized, double-blind, placebo-controlled, parallel-group study, 16 patients with a history of ischemic stroke/transient ischemic attack received oral levosimendan in 5 escalating doses from 0.125 to 2.0 mg daily for 18-day intervals of each dose; 5 patients received placebo. Twenty-four-hour ambulatory ECG and cerebral blood flow velocities using transcranial Doppler ultrasound were recorded at baseline and at the end of each dosing period. Vasomotor reactivity was assessed via the breath holding index. In addition, plasma levels of N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) and the metabolites of levosimendan were determined.Levosimendan induced an increase in cerebral blood flow velocities and a decrease in NT-pro-BNP compared with placebo. There was no significant effect on breath holding index. Doses ≥0.5 mg increased heart rate by 5 to 9 beats/min. The dose level of 2.0 mg exceeded the preset safety margin of ventricular extrasystoles per hour (ie, upper 90% CI of the ratio of levosimendan to placebo above 2) with an estimate of 3.10 (90% CI, 0.95-10.07).Oral levosimendan increases cerebral blood flow velocities and diminishes NT-pro-BNP levels in patients with earlier ischemic cerebrovascular event. Daily doses up to 1.0 mg were well tolerated, whereas the 2.0 mg dose level induced an increase in ventricular extrasystoles. ClinicalTrials.gov identifier: NCT00698763." @default.
• W2095387515 created "2016-06-24" @default.
• W2095387515 creator A5007512767 @default.
• W2095387515 creator A5007639476 @default.
• W2095387515 creator A5027601842 @default.
• W2095387515 creator A5057723078 @default.
• W2095387515 creator A5064992854 @default.
• W2095387515 creator A5076278333 @default.
• W2095387515 creator A5087566716 @default.
• W2095387515 date "2015-12-01" @default.
• W2095387515 modified "2023-09-23" @default.
• W2095387515 title "Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study" @default.
• W2095387515 cites W1748374584 @default.
• W2095387515 cites W1969116132 @default.
• W2095387515 cites W1998488091 @default.
• W2095387515 cites W1999005817 @default.
• W2095387515 cites W1999065909 @default.
• W2095387515 cites W2004056437 @default.
• W2095387515 cites W2006835595 @default.
• W2095387515 cites W2023005794 @default.
• W2095387515 cites W2024338419 @default.
• W2095387515 cites W2029737786 @default.
• W2095387515 cites W2032520387 @default.
• W2095387515 cites W2033971063 @default.
• W2095387515 cites W2058542276 @default.
• W2095387515 cites W2066118369 @default.
• W2095387515 cites W2071172543 @default.
• W2095387515 cites W2086408522 @default.
• W2095387515 cites W2089707647 @default.
• W2095387515 cites W2094831652 @default.
• W2095387515 cites W2126491128 @default.
• W2095387515 cites W2127139759 @default.
• W2095387515 cites W2156346178 @default.
• W2095387515 cites W2194129453 @default.
• W2095387515 cites W2312185933 @default.
• W2095387515 cites W36293374 @default.
• W2095387515 cites W1976233909 @default.
• W2095387515 doi "https://doi.org/10.1016/j.curtheres.2015.01.001" @default.
• W2095387515 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4461857" @default.
• W2095387515 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26082815" @default.
• W2095387515 hasPublicationYear "2015" @default.
• W2095387515 type Work @default.
• W2095387515 sameAs 2095387515 @default.
• W2095387515 citedByCount "12" @default.
• W2095387515 countsByYear W20953875152016 @default.
• W2095387515 countsByYear W20953875152017 @default.
• W2095387515 countsByYear W20953875152018 @default.
• W2095387515 countsByYear W20953875152019 @default.
• W2095387515 countsByYear W20953875152020 @default.
• W2095387515 countsByYear W20953875152022 @default.
• W2095387515 countsByYear W20953875152023 @default.
• W2095387515 crossrefType "journal-article" @default.
• W2095387515 hasAuthorship W2095387515A5007512767 @default.
• W2095387515 hasAuthorship W2095387515A5007639476 @default.
• W2095387515 hasAuthorship W2095387515A5027601842 @default.
• W2095387515 hasAuthorship W2095387515A5057723078 @default.
• W2095387515 hasAuthorship W2095387515A5064992854 @default.
• W2095387515 hasAuthorship W2095387515A5076278333 @default.
• W2095387515 hasAuthorship W2095387515A5087566716 @default.
• W2095387515 hasBestOaLocation W20953875151 @default.
• W2095387515 hasConcept C126322002 @default.
• W2095387515 hasConcept C127413603 @default.
• W2095387515 hasConcept C142724271 @default.
• W2095387515 hasConcept C157767197 @default.
• W2095387515 hasConcept C164705383 @default.
• W2095387515 hasConcept C191616109 @default.
• W2095387515 hasConcept C204787440 @default.
• W2095387515 hasConcept C27081682 @default.
• W2095387515 hasConcept C2775846464 @default.
• W2095387515 hasConcept C2775915353 @default.
• W2095387515 hasConcept C2777335384 @default.
• W2095387515 hasConcept C2778198053 @default.
• W2095387515 hasConcept C2780645631 @default.
• W2095387515 hasConcept C35785553 @default.
• W2095387515 hasConcept C42219234 @default.
• W2095387515 hasConcept C71924100 @default.
• W2095387515 hasConcept C78519656 @default.
• W2095387515 hasConceptScore W2095387515C126322002 @default.
• W2095387515 hasConceptScore W2095387515C127413603 @default.
• W2095387515 hasConceptScore W2095387515C142724271 @default.
• W2095387515 hasConceptScore W2095387515C157767197 @default.
• W2095387515 hasConceptScore W2095387515C164705383 @default.
• W2095387515 hasConceptScore W2095387515C191616109 @default.
• W2095387515 hasConceptScore W2095387515C204787440 @default.
• W2095387515 hasConceptScore W2095387515C27081682 @default.
• W2095387515 hasConceptScore W2095387515C2775846464 @default.
• W2095387515 hasConceptScore W2095387515C2775915353 @default.
• W2095387515 hasConceptScore W2095387515C2777335384 @default.
• W2095387515 hasConceptScore W2095387515C2778198053 @default.
• W2095387515 hasConceptScore W2095387515C2780645631 @default.
• W2095387515 hasConceptScore W2095387515C35785553 @default.
• W2095387515 hasConceptScore W2095387515C42219234 @default.
• W2095387515 hasConceptScore W2095387515C71924100 @default.
• W2095387515 hasConceptScore W2095387515C78519656 @default.
• W2095387515 hasLocation W20953875151 @default.
• W2095387515 hasLocation W20953875152 @default.
• W2095387515 hasLocation W20953875153 @default.
• W2095387515 hasLocation W20953875154 @default.

• next